NSE filing, NSE: KOPRAN. Summary written from the filing by ALFA Finder's alert engine.
Kopran Ltd: key numbers
- Share price
- ₹239.05
- Market cap
- ₹1,155 Cr
- Revenue (annual)
- ₹681.4 Cr
- Net profit (annual)
- ₹25.73 Cr
- P/E (TTM)
- 46.2×Sector 45.9×
- Promoter holding
- 41.82%-2.60% QoQ
- FII holding
- 0.91%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kopran Ltd
All →Kopran Board Meeting Date
Kopran Ltd intimates a board meeting on November 3, 2026, to consider and approve Q2 FY27 unaudited financial results. No financial figures are disclosed in this advance notice.
Kopran Business Update
Kopran's Khopoli formulation facility concluded an EU GMP inspection with no critical or data-integrity observations. The company will submit compliance responses for one major and minor findings within two weeks.
Kopran Other Announcement
Kopran Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Kopran Promoter Buying
Sarvamangal Mercantile Company Limited acquired 170,000 shares of Kopran Ltd through market purchases. The transaction increases the promoter group's stake in the target company by 0.35%.
- Promoter stake change
- +0.35%
Kopran Price Movement Clarification
Kopran Limited responded to NSE's price-movement query stating no material information was withheld. The stock's rise is attributed to purely market-driven forces.
Kopran Employee Stock Options
Kopran Limited allotted 40,500 equity shares to employees under its ESOP 2023 scheme. The exercise price for these shares is Rs 179 per share.
- Value
- ₹0.72 Cr
Other annual general meeting announcements
All →TeleCanor Global Annual General Meeting
TeleCanor Global held its 34th AGM on 31-Oct-2026 and the proceedings were filed with the exchange. Two ordinary resolutions were put to members, covering adoption of FY2026 accounts and re-appointment of a retiring director.
Sun Pharmaceutical Industries Annual General Meeting
Sun Pharma's postal ballot passed all seven special resolutions, including ESOP 2026 approval and borrowing and security limits. No monetary transaction is stated.
Bondada Engineering Annual General Meeting
Bondada Engineering Ltd has called an extraordinary general meeting on 21 November 2026. Shareholders will vote on related-party loans, security creation and borrowing limits.
Uflex Annual General Meeting
Uflex shareholders approved a special resolution to borrow up to ₹5,000 Crore under Section 180(1)(c) via postal ballot, with 99.92% in favour. The result was declared on 31 October 2026.
Stovec Industries Annual General Meeting
Stovec Industries' shareholders approved two non-executive director appointments by postal ballot. Both resolutions passed with about 98% of votes polled in favour.
Innovators Facade Systems Annual General Meeting
EOGM on 25 Nov 2026 seeks approval for 9,50,971 preferential shares and a related-party share acquisition. Transaction value is Rs 11.22 Crore.
- Value
- ₹11.22 Cr
- Execution
- 25-11-2026 to 24-05-2027